These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 28689345
1. Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease. Chong S, Park JD, Chae JH, Cheon JE, Kim SK, Phi JH, Lee JY, Paeng JC, Wang KC. Childs Nerv Syst; 2017 Nov; 33(11):2029-2033. PubMed ID: 28689345 [Abstract] [Full Text] [Related]
2. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, Kang E, Lee DS. Stroke; 2005 Jul; 36(7):1485-9. PubMed ID: 15947261 [Abstract] [Full Text] [Related]
3. Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease. Han JH, Park YS, Lee WH, Koong SS, Min KS, Lee MS, Kim YG, Kim DH, Yi KS, Cha SH. Childs Nerv Syst; 2016 Aug; 32(8):1471-7. PubMed ID: 26661381 [Abstract] [Full Text] [Related]
4. Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease. Setta K, Kojima D, Shimada Y, Yoshida J, Oshida S, Fujimoto K, Tsutsui S, Chiba T, Fujiwara S, Terasaki K, Ogasawara K. Ann Nucl Med; 2018 Nov; 32(9):611-619. PubMed ID: 30030783 [Abstract] [Full Text] [Related]
5. Cerebrovascular Events During Pregnancy and Puerperium Resulting from Preexisting Moyamoya Disease: Determining the Risk of Ischemic Events Based on Hemodynamic Status Assessment Using Brain Perfusion Single-Photon Emission Computed Tomography. Lee SU, Chung YS, Oh CW, Kwon OK, Bang JS, Hwang G, Kim T, Ahn SY. World Neurosurg; 2016 Jun; 90():66-75. PubMed ID: 26906896 [Abstract] [Full Text] [Related]
8. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. Hayashi T, Shirane R, Fujimura M, Tominaga T. J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991 [Abstract] [Full Text] [Related]
9. Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT. Song YS, Oh SW, Kim YK, Kim SK, Wang KC, Lee DS. Ann Nucl Med; 2012 Jan; 26(1):47-57. PubMed ID: 22033781 [Abstract] [Full Text] [Related]
10. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. Hoshi H, Ohnishi T, Jinnouchi S, Futami S, Nagamachi S, Kodama T, Watanabe K, Ueda T, Wakisaka S. J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059 [Abstract] [Full Text] [Related]
11. Diagnostic imaging of higher brain dysfunction in patients with adult moyamoya disease using statistical imaging analysis for [123I]iomazenil single photon emission computed tomography. Nakagawara J, Osato T, Kamiyama K, Honjo K, Sugio H, Fumoto K, Murahashi T, Takada H, Watanabe T, Nakamura H. Neurol Med Chir (Tokyo); 2012 Jan; 52(5):318-26. PubMed ID: 22688069 [Abstract] [Full Text] [Related]
12. CT perfusion with angiography as a substitute for both conventional digital subtraction angiography and acetazolamide-challenged SPECT in the follow-up of postbypass patients. Park JC, Kim JE, Kang HS, Sohn CH, Lee DS, Oh CW, Han MH. Cerebrovasc Dis; 2010 Jan; 30(6):547-55. PubMed ID: 20948198 [Abstract] [Full Text] [Related]
13. [Enlargement of cerebral infarction after CBF study with acetazolamide challenge: two case report]. Meguro T, Tanabe T, Muraoka K, Terada K, Hirotsune N, Nishino S. No Shinkei Geka; 2009 Feb; 37(2):183-8. PubMed ID: 19227161 [Abstract] [Full Text] [Related]
15. Voxel Based Analysis of Surgical Revascularization for Moyamoya Disease: Pre- and Postoperative SPECT Studies. Fushimi Y, Okada T, Takagi Y, Funaki T, Takahashi JC, Miyamoto S, Togashi K. PLoS One; 2016 Feb; 11(2):e0148925. PubMed ID: 26867219 [Abstract] [Full Text] [Related]
16. [Usefulness of 123I-amphetamine SPECT in evaluation of cerebral circulation by the acetazolamide test in patients with moyamoya disease]. Fuse T, Takagi T. No To Hattatsu; 1993 Mar; 25(2):183-5. PubMed ID: 8461169 [No Abstract] [Full Text] [Related]
17. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease. Inoue Y, Momose T, Machida K, Honda N, Tsutsumi K. J Nucl Med; 1993 Nov; 34(11):1984-6. PubMed ID: 8229245 [Abstract] [Full Text] [Related]
18. Metabolic changes after H(2) 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases. Muroi C, Yonekawa Y, Khan N, Pangalu A, Keller E. J Neurosurg Anesthesiol; 2003 Apr; 15(2):131-9. PubMed ID: 12657999 [Abstract] [Full Text] [Related]
19. In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease. Kim YI, Phi JH, Paeng JC, Choi H, Kim SK, Lee YS, Kang KW, Lee JY, Jeong JM, Chung JK, Lee DS, Wang KC. J Nucl Med; 2014 Sep; 55(9):1467-72. PubMed ID: 25060195 [Abstract] [Full Text] [Related]
20. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease. Kawabori M, Kuroda S, Nakayama N, Hirata K, Shiga T, Houkin K, Tamaki N. World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]